2023 Q3 Form 10-Q Financial Statement
#000138865823000105 Filed on August 04, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
Revenue | $124.6M | $124.1M | $102.1M |
YoY Change | 19.96% | 21.64% | 25.56% |
Cost Of Revenue | $42.13M | $37.91M | $31.81M |
YoY Change | 27.84% | 19.18% | 22.35% |
Gross Profit | $82.47M | $86.23M | $70.25M |
YoY Change | 16.29% | 22.75% | 27.06% |
Gross Profit Margin | 66.19% | 69.46% | 68.83% |
Selling, General & Admin | $93.77M | $91.42M | $81.75M |
YoY Change | 16.4% | 11.83% | 30.45% |
% of Gross Profit | 113.69% | 106.02% | 116.38% |
Research & Development | $16.31M | $13.68M | $11.95M |
YoY Change | 42.46% | 14.5% | 24.35% |
% of Gross Profit | 19.77% | 15.86% | 17.0% |
Depreciation & Amortization | $4.100M | $3.800M | $3.351M |
YoY Change | 19.32% | 13.4% | 55.93% |
% of Gross Profit | 4.97% | 4.41% | 4.77% |
Operating Expenses | $110.1M | $105.1M | $93.70M |
YoY Change | 19.64% | 12.17% | 29.64% |
Operating Profit | -$27.60M | -$18.87M | -$23.45M |
YoY Change | 30.91% | -19.53% | 38.01% |
Interest Expense | $927.0K | $832.0K | $482.0K |
YoY Change | -250.98% | 72.61% | 57.0% |
% of Operating Profit | |||
Other Income/Expense, Net | $1.600M | $1.435M | $69.00K |
YoY Change | 338.36% | 1979.71% | 25.45% |
Pretax Income | -$26.92M | -$18.27M | -$23.86M |
YoY Change | 26.18% | -23.45% | 38.39% |
Income Tax | $195.0K | $213.0K | $33.00K |
% Of Pretax Income | |||
Net Earnings | -$27.12M | -$18.48M | -$23.90M |
YoY Change | 26.41% | -22.66% | 37.66% |
Net Earnings / Revenue | -21.76% | -14.89% | -23.42% |
Basic Earnings Per Share | -$0.89 | -$0.61 | -$0.80 |
Diluted Earnings Per Share | -$0.89 | -$0.61 | -$0.80 |
COMMON SHARES | |||
Basic Shares Outstanding | 30.58M shares | 30.47M shares | 29.84M shares |
Diluted Shares Outstanding | 30.61M shares | 30.50M shares | 29.84M shares |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $158.5M | $164.7M | $204.5M |
YoY Change | -22.14% | -19.44% | -20.02% |
Cash & Equivalents | $47.48M | $61.58M | $101.3M |
Short-Term Investments | $111.0M | $103.2M | $103.2M |
Other Short-Term Assets | $12.10M | $11.82M | $8.526M |
YoY Change | 65.17% | 38.59% | 18.11% |
Inventory | $13.65M | $14.48M | $14.42M |
Prepaid Expenses | |||
Receivables | $50.07M | $51.11M | $57.38M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $234.3M | $242.1M | $284.8M |
YoY Change | -18.04% | -14.98% | -15.12% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $96.67M | $89.85M | $65.92M |
YoY Change | -27.6% | 36.29% | 40.01% |
Goodwill | $862.0K | $862.0K | $862.0K |
YoY Change | 0.0% | 0.0% | 0.0% |
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $47.05M | $38.72M | $20.14M |
YoY Change | 133.45% | 92.25% | 42.09% |
Total Long-Term Assets | $205.5M | $187.3M | $150.9M |
YoY Change | 32.96% | 24.18% | 0.81% |
TOTAL ASSETS | |||
Total Short-Term Assets | $234.3M | $242.1M | $284.8M |
Total Long-Term Assets | $205.5M | $187.3M | $150.9M |
Total Assets | $439.8M | $429.5M | $435.7M |
YoY Change | -0.14% | -1.42% | -10.21% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $7.212M | $7.150M | $5.987M |
YoY Change | -2.59% | 19.43% | -33.07% |
Accrued Expenses | $76.63M | $64.47M | $49.95M |
YoY Change | 4.71% | 29.06% | 17.27% |
Deferred Revenue | $3.400M | $3.695M | $2.977M |
YoY Change | 13.22% | 24.12% | 18.75% |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | $0.00 | |
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $102.3M | $89.41M | $70.42M |
YoY Change | 22.37% | 26.98% | -3.56% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $34.95M | $34.94M | $34.93M |
YoY Change | 0.04% | 0.04% | 125.12% |
Other Long-Term Liabilities | $1.013M | $1.012M | $952.0K |
YoY Change | -98.77% | 6.3% | -57.97% |
Total Long-Term Liabilities | $35.96M | $35.95M | $35.88M |
YoY Change | -69.42% | 0.21% | 101.79% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $102.3M | $89.41M | $70.42M |
Total Long-Term Liabilities | $35.96M | $35.95M | $35.88M |
Total Liabilities | $220.0M | $205.6M | $191.0M |
YoY Change | 9.35% | 7.62% | 6.86% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$606.9M | -$579.8M | -$480.6M |
YoY Change | 20.9% | 20.65% | 37.37% |
Common Stock | $826.7M | $803.8M | $725.8M |
YoY Change | 11.43% | 10.75% | 10.59% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $219.8M | $223.9M | $244.6M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $439.8M | $429.5M | $435.7M |
YoY Change | -0.14% | -1.42% | -10.21% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$27.12M | -$18.48M | -$23.90M |
YoY Change | 26.41% | -22.66% | 37.66% |
Depreciation, Depletion And Amortization | $4.100M | $3.800M | $3.351M |
YoY Change | 19.32% | 13.4% | 55.93% |
Cash From Operating Activities | $1.200M | -$4.572M | -$372.0K |
YoY Change | -67.29% | 1129.03% | -31.74% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $9.090M | $9.397M | -$10.83M |
YoY Change | -243.53% | -186.75% | 82.85% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$6.350M | $18.41M | $10.40M |
YoY Change | -78.13% | 76.96% | 36.48% |
Cash From Investing Activities | -$15.44M | $9.009M | -$431.0K |
YoY Change | -56.34% | -2190.26% | -125.4% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 60.00K | 4.381M | 7.270M |
YoY Change | -96.39% | -39.74% | 2025.73% |
NET CHANGE | |||
Cash From Operating Activities | 1.200M | -4.572M | -372.0K |
Cash From Investing Activities | -15.44M | 9.009M | -431.0K |
Cash From Financing Activities | 60.00K | 4.381M | 7.270M |
Net Change In Cash | -14.18M | 8.818M | 6.467M |
YoY Change | -52.78% | 36.35% | 332.86% |
FREE CASH FLOW | |||
Cash From Operating Activities | $1.200M | -$4.572M | -$372.0K |
Capital Expenditures | $9.090M | $9.397M | -$10.83M |
Free Cash Flow | -$7.890M | -$13.97M | $10.46M |
YoY Change | -178.88% | -233.55% | 94.46% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
30577519 | shares |
dei |
Security12b Title
Security12bTitle
|
Common Stock, Par Value $0.001 Per Share | ||
dei |
Trading Symbol
TradingSymbol
|
IRTC | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30550000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
30550000 | shares |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.80 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.80 | |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
29843000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
29843000 | shares |
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
141000 | usd | |
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
227000 | usd | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
239812000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
905000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
19899000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-39109000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
327000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
221834000 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-44000 | usd |
us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
0 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contractual allowances, allowance for doubtful accounts, the useful lives of property and equipment, the recoverability of long-lived assets including the estimated usage of the printed circuit board assemblies (“PCBAs”), the incremental borrowing rate for operating leases, accounting for income taxes, impairment of ROU assets, and various inputs used in estimating stock-based compensation. Actual results may differ from those estimates.</span></div> | ||
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
18475000 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
14012000 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
14012000 | usd |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
9424000 | usd | |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
17191000 | usd |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
7623000 | usd | |
irtc |
Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
|
8489000 | usd | |
CY2022 | irtc |
Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
|
12728000 | usd |
irtc |
Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
|
7000 | usd | |
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
19410000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
18475000 | usd |
CY2022Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
21628000 | usd |
CY2022Q4 | irtc |
Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
|
41389000 | usd |
CY2021Q4 | irtc |
Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
|
31274000 | usd |
CY2021Q4 | irtc |
Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
|
31274000 | usd |
irtc |
Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
|
28062000 | usd | |
CY2022 | irtc |
Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
|
41158000 | usd |
irtc |
Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
|
21626000 | usd | |
irtc |
Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
|
21537000 | usd | |
CY2022 | irtc |
Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
|
31043000 | usd |
irtc |
Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
|
38000 | usd | |
CY2023Q2 | irtc |
Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
|
47914000 | usd |
CY2022Q4 | irtc |
Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
|
41389000 | usd |
CY2022Q2 | irtc |
Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
|
52862000 | usd |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, investments and accounts receivable. Cash balances are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, U.S. government securities, corporate notes, commercial paper and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments.</span></div>Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers comprising the Company’s customer base and their dispersion across many geographies. The Company does not require collateral. The Company records an allowance for doubtful accounts based on the assessment of the collectability of customer accounts, considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer’s ability to pay. | ||
CY2023Q2 | irtc |
Number Of Zio System Options
NumberOfZioSystemOptions
|
3 | systemoption |
CY2023Q2 | irtc |
Number Of Performance Obligations
NumberOfPerformanceObligations
|
2 | performanceobligation |
CY2023Q2 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
3000000 | usd |
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
3000000 | usd | |
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
3000000 | usd | |
CY2023Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
131779000 | usd |
CY2023Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
4000 | usd |
CY2023Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
113000 | usd |
CY2023Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
131670000 | usd |
CY2023Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
28509000 | usd |
CY2023Q2 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
103161000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
131670000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
158972000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
12000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
409000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
158575000 | usd |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
24263000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
134312000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
158575000 | usd |
CY2023Q2 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
131670000 | usd |
CY2022Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
158575000 | usd |
CY2023Q2 | us-gaap |
Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
|
7208000 | usd |
CY2022Q4 | us-gaap |
Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
|
9338000 | usd |
CY2023Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
7270000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
5817000 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
14478000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
15155000 | usd |
CY2023Q2 | irtc |
Printed Circuit Board Assemblies
PrintedCircuitBoardAssemblies
|
30153000 | usd |
CY2022Q4 | irtc |
Printed Circuit Board Assemblies
PrintedCircuitBoardAssemblies
|
18599000 | usd |
CY2023Q2 | irtc |
Cloud Computing Arrangements
CloudComputingArrangements
|
4443000 | usd |
CY2022Q4 | irtc |
Cloud Computing Arrangements
CloudComputingArrangements
|
2523000 | usd |
CY2023Q2 | irtc |
Strategic Investment
StrategicInvestment
|
3000000 | usd |
CY2022Q4 | irtc |
Strategic Investment
StrategicInvestment
|
0 | usd |
CY2023Q2 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
1127000 | usd |
CY2022Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
1130000 | usd |
CY2023Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
38723000 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
22252000 | usd |
irtc |
Assets Purchase Accounting Adjustments
AssetsPurchaseAccountingAdjustments
|
11600000 | usd | |
CY2023Q2 | us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
0 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
132156000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
110886000 | usd |
CY2023Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
42311000 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
35216000 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
89845000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
75670000 | usd |
CY2023Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3800000 | usd |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7400000 | usd | |
CY2022Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3400000 | usd |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
6500000 | usd | |
CY2023Q2 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
2800000 | usd |
us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
5500000 | usd | |
CY2022Q2 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
2500000 | usd |
us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
4700000 | usd | |
CY2023Q2 | us-gaap |
Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
|
8900000 | usd |
us-gaap |
Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
|
16800000 | usd | |
CY2023Q2 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
27159000 | usd |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
34752000 | usd |
CY2023Q2 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
10041000 | usd |
CY2022Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
8608000 | usd |
CY2023Q2 | irtc |
Accrued Expenses Current
AccruedExpensesCurrent
|
10255000 | usd |
CY2022Q4 | irtc |
Accrued Expenses Current
AccruedExpensesCurrent
|
7006000 | usd |
CY2023Q2 | irtc |
Claims Payable Current
ClaimsPayableCurrent
|
7257000 | usd |
CY2022Q4 | irtc |
Claims Payable Current
ClaimsPayableCurrent
|
4464000 | usd |
CY2023Q2 | irtc |
Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
|
1090000 | usd |
CY2022Q4 | irtc |
Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
|
1045000 | usd |
CY2023Q2 | irtc |
Accrued State Local And Foreign Taxes
AccruedStateLocalAndForeignTaxes
|
2604000 | usd |
CY2022Q4 | irtc |
Accrued State Local And Foreign Taxes
AccruedStateLocalAndForeignTaxes
|
2388000 | usd |
CY2023Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
6063000 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
7234000 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
64469000 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
65497000 | usd |
us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
3100000 | usd | |
us-gaap |
Professional Fees
ProfessionalFees
|
800000 | usd | |
CY2022Q1 | irtc |
Reduction To Leased Square Footage Percent
ReductionToLeasedSquareFootagePercent
|
0.50 | |
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
23200000 | usd | |
us-gaap |
Restructuring Charges
RestructuringCharges
|
3444000 | usd | |
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
23164000 | usd | |
us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
26608000 | usd | |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
10417000 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
20592000 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
20385000 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
20136000 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
19736000 | usd |
CY2023Q2 | irtc |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
36124000 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
127390000 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
33049000 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
94341000 | usd |
CY2023Q2 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1800000 | usd |
CY2023Q2 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
8400000 | usd |
CY2023Q2 | irtc |
Operating Loss Carryforwards Tax Benefit Recognized
OperatingLossCarryforwardsTaxBenefitRecognized
|
0 | usd |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
us-gaap |
Dividends Common Stock
DividendsCommonStock
|
0 | usd | |
CY2023Q2 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
9865000 | shares |
CY2022Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
10177000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
328000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
43.00 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y5M4D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
16635000 | usd |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
19000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
54.14 | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
309000 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
42.31 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y10M28D | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
19161000 | usd |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
309000 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
42.31 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y10M28D | ||
CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
19161000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares | |
CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
14099000 | usd |
CY2022Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
15098000 | usd |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
32350000 | usd | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
29001000 | usd | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18482000 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-23897000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-57591000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-74506000 | usd | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30502000 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30502000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
29843000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
29843000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30400000 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30400000 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
29720000 | shares | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.61 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.61 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.80 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.80 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.89 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.89 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.51 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2827000 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2398000 | shares | |
CY2023Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false |